Uncategorized

Pfizer Halts Obesity-Drug Development. What It Means for Eli Lilly, Novo Nordisk. – Barron’s

Posted on Author Tim Hodges Comments Off on Pfizer Halts Obesity-Drug Development. What It Means for Eli Lilly, Novo Nordisk. – Barron’s
  1. Pfizer Halts Obesity-Drug Development. What It Means for Eli Lilly, Novo Nordisk.  Barron’s
  2. Pfizer scraps daily weight loss pill after liver injury in one patient  CNBC
  3. What’s Pfizer’s next move after shelving its oral obesity drug danuglipron?  Endpoints News
  4. Wegovy, Zepbound makers’ stocks rally as a weight-loss-drug competitor drops out  MarketWatch
  5. Pfizer will end development of daily anti-obesity pill due to liver injury  The Hill